Antinuclear antibodies (ANA) patterns in paraneoplastic cerebellar degeneration during the course of disease and treatment protocols – A case report

Venkatraman, 2016, Paraneoplastic cerebellar degeneration with anti-Yo antibodies – a review, Annals of Clinical and Translational Neurology, 3, 655, 10.1002/acn3.328 Tschernatsch, 2005, Antinuclear antibodies define a subgroup of paraneoplastic neuropathies: clinical and immunological data, J. Neurol. Neurosurg. Psychiatr., 76, 1702, 10.1136/jnnp.2003.033225 Vermeersch, 2013, Prevalence and clinical significance of rare antinuclear antibody patterns, Autoimmun. Rev., 12, 998, 10.1016/j.autrev.2013.03.014 Tan, 2017, The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC), American Journal of Clinical and Experimental Immunology, 6, 21 Jarius, 2015, “Medusa head ataxia”: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook, J. Neuroinflammation, 12, 168, 10.1186/s12974-015-0358-9 Welner, 2013, Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay, Mol. Canc., 12, 95, 10.1186/1476-4598-12-95 Chiaie, 2012, Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status. Clinical Practice and Epidemiology in mental Health, CP & EMH, 8, 81 Aguirre-Cruz, 2005, Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases, J. Neuro Oncol., 71, 39, 10.1007/s11060-004-4536-3 Solans-Laqué, 2004, Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes, Lupus, 13, 159, 10.1191/0961203304lu521oa Westra, 2003, Antinucleair antibody (ANA) positivity caused by paraneoplastic antibodies due to abundant p53 expression in early hepatic carcinoma, Neth. J. Med., 61, 300 Moll, 1996, Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease, Neurol., 243, 51, 10.1007/BF00878531 Koh, 1995, Characterisation of anticytoplasmic antibodies and their clinical associations, Ann. Rheum. Dis., 54, 269, 10.1136/ard.54.4.269 Damoiseaux, 2019, Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective, Ann. Rheum. Dis., 78, 879, 10.1136/annrheumdis-2018-214436